These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30125662)

  • 1. Prophylactic and therapeutic inhibition of allergic airway inflammation by probiotic Escherichia coli O83.
    Zwicker C; Sarate P; Drinić M; Ambroz K; Korb E; Smole U; Köhler C; Wilson MS; Kozakova H; Sebo P; Kverka M; Wiedermann U; Schabussova I
    J Allergy Clin Immunol; 2018 Dec; 142(6):1987-1990.e7. PubMed ID: 30125662
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic efficacy of an E coli strain carrying an ovalbumin allergenic peptide as a fused protein to OMPC in a murine model of allergic airway inflammation.
    Yépez SH; Pando RH; Argumedo LS; Paredes MV; Cueto AH; Isibasi A; Bonilla CR
    Vaccine; 2003 Jan; 21(5-6):566-78. PubMed ID: 12531657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Effects of Particulate Matter on House Dust Mite and Ovalbumin Allergic Airway Inflammation in Mice.
    Castañeda AR; Pinkerton KE
    Curr Protoc Toxicol; 2016 May; 68():18.18.1-18.18.18. PubMed ID: 27145110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma.
    Wang Y; McCusker CT
    Clin Exp Allergy; 2005 Aug; 35(8):1104-11. PubMed ID: 16120094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific CTL require perforin expression to suppress allergic airway inflammation.
    Enomoto N; Hyde E; Ma JZ; Yang J; Forbes-Blom E; Delahunt B; Le Gros G; Ronchese F
    J Immunol; 2012 Feb; 188(4):1734-41. PubMed ID: 22250087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin protects BALB/c mice from mite-induced airway allergic inflammation.
    Fu LS; Tsai JJ; Chen YJ; Lin HK; Tsai MC; Chang MD
    Int J Immunopathol Pharmacol; 2013; 26(2):349-59. PubMed ID: 23755750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVA-Induced Allergic Airway Inflammation Mouse Model.
    Casaro M; Souza VR; Oliveira FA; Ferreira CM
    Methods Mol Biol; 2019; 1916():297-301. PubMed ID: 30535706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation.
    Edwan JH; Perry G; Talmadge JE; Agrawal DK
    J Immunol; 2004 Apr; 172(8):5016-23. PubMed ID: 15067083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.
    Bickert T; Trujillo-Vargas CM; Duechs M; Wohlleben G; Polte T; Hansen G; Oelschlaeger TA; Erb KJ
    Int Arch Allergy Immunol; 2009; 149(3):219-30. PubMed ID: 19218814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice.
    Juan Z; Zhao-Ling S; Ming-Hua Z; Chun W; Hai-Xia W; Meng-Yun L; Jian-Qiong H; Yue-Jie Z; Xin S
    Respirology; 2017 Jul; 22(5):898-904. PubMed ID: 28122397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with Flt3 ligand plasmid reverses allergic airway inflammation in ovalbumin-sensitized and -challenged mice.
    Edwan JH; Talmadge JE; Agrawal DK
    Int Immunopharmacol; 2005 Feb; 5(2):345-57. PubMed ID: 15652764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae.
    Preston JA; Essilfie AT; Horvat JC; Wade MA; Beagley KW; Gibson PG; Foster PS; Hansbro PM
    Vaccine; 2007 Nov; 25(48):8154-62. PubMed ID: 17950502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helminth infection modulates the development of allergen-induced airway inflammation.
    Wohlleben G; Trujillo C; Müller J; Ritze Y; Grunewald S; Tatsch U; Erb KJ
    Int Immunol; 2004 Apr; 16(4):585-96. PubMed ID: 15039389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
    Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
    Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice.
    Gerhold K; Avagyan A; Seib C; Frei R; Steinle J; Ahrens B; Dittrich AM; Blumchen K; Lauener R; Hamelmann E
    J Allergy Clin Immunol; 2006 Sep; 118(3):666-73. PubMed ID: 16950286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses.
    Kang JH; Kim BS; Uhm TG; Lee SH; Lee GR; Park CS; Chung IY
    Am J Respir Crit Care Med; 2009 May; 179(10):875-82. PubMed ID: 19234107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Toll-like receptor 2/6 agonist reduces allergic airway inflammation in chronic respiratory sensitisation to Timothy grass pollen antigens.
    Fuchs B; Knothe S; Rochlitzer S; Nassimi M; Greweling M; Lauenstein HD; Nassenstein C; Müller M; Ebensen T; Dittrich AM; Krug N; Guzman CA; Braun A
    Int Arch Allergy Immunol; 2010; 152(2):131-9. PubMed ID: 20016195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens.
    Brandt EB; Scribner TA; Akei HS; Rothenberg ME
    J Allergy Clin Immunol; 2006 Aug; 118(2):420-7. PubMed ID: 16890767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.